-
Mashup Score: 0VIDEO: ‘Distinctive shift’ in gut microbiota after Rebyota treatment for C. difficile - 12 month(s) ago
CHICAGO — In a Healio video exclusive, Ken Blount, PhD, discusses successful restoration of gut microbiota and clonal engraftment as soon as 1 week after treatment with Rebyota in those with recurrent Clostridioides difficile infection. Blount and colleagues sought to quantify and define clonal engraftment and durable microbiome compositional changes with FDA-approved Rebyota (fecal
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0FDA approves Vowst as first oral microbiota biotherapeutic for recurrent C. difficile - 1 year(s) ago
The FDA has approved Vowst, the first orally administered fecal microbiota product indicated for the prevention of recurrent Clostridioides difficile infection in adults following antibacterial treatment. With this approval, Vowst ( SER-109, Seres Therapeutics) becomes the second microbiota-based live biotherapeutic approved for recurrent C. difficile infection following the
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#ICYMI: @US_FDA approves Vowst (@SeresTX) as first oral microbiota biotherapeutic for recurrent #Cdifficile #GITwitter #MedTwitter https://t.co/1WvG0plks2
-
-
Mashup Score: 0
Can a patient catch C difficile if the previous hospital room occupant had it?
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
Is it possible for a patient to catch C difficile if the previous hospital room occupant had it? https://t.co/fWz3hePeUq #cdiff @JohnsHopkinsSPH #hai #cdifficile
-
-
Mashup Score: 1
Can a patient catch C difficile if the previous hospital room occupant had it?
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
Can a patient catch C difficile if the previous hospital room occupant had it? https://t.co/oC7d3hjWee #cdiff @JohnsHopkinsSPH #hai #cdifficile
-
-
Mashup Score: 0An interprofessional approach to reducing hospital-onset Clostridioides difficile infections - 1 year(s) ago
Clostridioides difficile is a Gram positive, spore-forming bacterium, transmitted via the fecal-oral route. C. difficile infection (CDI) occurs when the bacterium produces toxins, causing diarrhea and inflammation of the colon. Risk factors that have been associated with CDI include antibiotics, age 65 years or older, recent hospitalizations, weakened immune system, proton pump therapy and…
Categories: Infectious Disease, Latest HeadlinesTweet-
An #interprofessional approach to reducing hospital-onset #Cdifficile infections https://t.co/z0z4M1w54p
-
-
Mashup Score: 1
The FDA has approved Rebyota, a microbiota-based live biotherapeutic indicated for the prevention of recurrent Clostridioides difficile infection in adults after antibiotic treatment, Ferring Pharmaceuticals announced in a press release. The approval comes after an FDA panel voted in favor of Rebyota (fecal microbiota, live-jslm; Ferring Pharmaceuticals) in September 2022, with the Vaccines and
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#ICYMI: @US_FDA approves fecal microbiota biotherapeutic for recurrent #Cdifficile infection @ferring #GITwitter #Medtwitter https://t.co/XimIH2blxH
-
-
Mashup Score: 0
Any decrease in the devastation of Clostridioides difficile is welcomed, but an investigative team brought the numbers down by 50%. See what control measures they used.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
See how an investigative team brought down the Clostridioides difficile infections in 8 facilities. https://t.co/IZfHozZDXK @AHEtweets #cdiff #cdifficile #infectiousdisease #hospitalonset #HAI #Sanitisation
-
-
Mashup Score: 1
Any decrease in the devastation of Clostridioides difficile is welcomed, but an investigative team brought the numbers down by 50%. See how they did it.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
Any decrease to the devastation of Clostridioides difficile is welcomed, but an investigative team brought the numbers down by 50%. See how they did it. https://t.co/ncP2FWLghp @AHEtweets #cdiff #cdifficile #infectiousdisease #hospitalonset #HAI #Sanitisation
-
-
Mashup Score: 1
Any decrease in the devastation of Clostridioides difficile is welcomed, but an investigative team brought the numbers down by 50%. See how they did it.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
Any decrease in the devastation of Clostridioides difficile is welcomed, but an investigative team brought the numbers down by 50%. See how they did it. https://t.co/uaEifnJTWw @AHEtweetsin #cdiff #cdifficile #infectiousdisease #hospitalonset #HAI #Sanitisation
-
-
Mashup Score: 0First-line Fecal Microbiota Transplantation Offers Resolution for Patients With Clostridiodes difficile, Study Says - 2 year(s) ago
Microbiota restoration may be a solution for effectively treating patients with Clostridiodes difficile infection, according to researchers.
Source: AJMCCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
A clinical trial found evidence supporting first-line fecal microbiota transplantation, in addition to #vancomycin, may be an effective treatment for early #Cdifficile infection. Keep reading: https://t.co/1keXGDIYo4 https://t.co/TL8Q7Jul4I
-
#ICYMI with @KenBlountPhD at #DDW23: ‘Distinctive shift’ in #gutmicrobiota after #Rebyota ( @FerringMBiome) treatment for #Cdifficile @DDWMeeting https://t.co/5OfW7hBH0A